Germaine G Fuh

This inventor holds 43 USPTO granted patents and 16 published patent applications, plus 6 CIPO patents and 13 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Genentech, Inc., Genetech, Inc., 23Andme, Inc.. Active years: 1998-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Germaine G Fuh. Retrieved from https://idiyas.com/inventor/germaine-g-fuh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 43 (Patent Applications = 16)

% Patents Active = 86.0

CIPO Patents = 6

EPO Patents = 13 (Patent Applications = 15)

Average Co-Inventor Count = 3.7

ph-index = 14

Forward Citations = 748(Granted Patents)

Location History:

San Francisco, CA (US) (2002)
South San Francisco, CA (US) (2016)
Pacifica, CA (US) (1998 - 2024)

Company Filing History:

Years Active: 1998-2024

Loading Chart...

Areas of Expertise:

Anti-VEGF Antibodies

Multispecific Antibodies

Dual Specific Antibodies

Ocular Disorders

Hyaluronic Acid Polymer

Anti-HtrA1 Antibodies

Anti-CD3 Antibodies

Ligand Antagonists

Synthetic Antibody Libraries

Polynucleotides

Interleukin Binding

Breast Cancer Treatment

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12121586 - Optimized variants of anti-VEGF antibodies (2024-10-22),

2. 12060426 - Anti-ULBP6 antibodies (2024-08-13),

3. 12006360 - Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5) (2024-06-11),

4. 11891437 - Methods of treating ocular disorders by administering a VEGF-binding antibody covalently linked to a hyaluronic acid polymer (2024-02-06),

5. 11851501 - Multispecific antibodies (2023-12-26),

6. 11512143 - Anti-HtrA1 antibodies and methods of use thereof (2022-11-29),

7. 11111291 - Conjugates comprising a vascular endothelial growth factor (VEGF) antibody and a hyaluronic acid polymer (2021-09-07),

8. 11008401 - Multispecific antibodies (2021-05-18),

9. 11007267 - Anti-CD3 antibodies and methods of use (2021-05-18),

10. 10906968 - Polynucleotides encoding optimized variants of anti-VEGF antibodies (2021-02-02),

11. 10899828 - Optimized variants of anti-vegf antibodies and methods of use thereof in treatment (2021-01-26),

12. 10683348 - Dual specific antibodies (2020-06-16),

13. 10421822 - Anti-HtrA1 antibodies and methods of use thereof (2019-09-24),

14. 10421821 - Anti-HtrA1 antibodies and methods of use thereof (2019-09-24),

15. 10118970 - Multispecific antibodies (2018-11-06),

Title: The Innovative Mind of Germaine G Fuh

Introduction: Germaine G Fuh, a talented inventor hailing from Pacifica, CA (US), is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Germaine G Fuh has recently been granted several patents for his cutting-edge inventions in the realm of artificial intelligence and renewable energy technologies.

Career Highlights: With a career spanning over two decades, Germaine G Fuh has established himself as a visionary in the tech industry. His work has revolutionized the way we approach sustainability and efficiency in various sectors.

Collaborations: Throughout his career, Germaine G Fuh has collaborated with leading research institutions, universities, and tech companies to further advance his innovative ideas. His collaborative spirit has led to the development of groundbreaking technologies that have the potential to shape the future.

Conclusion: Germaine G Fuh's passion for innovation and his relentless pursuit of technological advancement have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire and pave the way for a more sustainable and technologically advanced future.

Profile summary based on public USPTO records.